Advances in Sepsis Research - 24/08/15
Résumé |
Recent research has identified promising targets for therapeutic interventions aimed at modulating the inflammatory response in sepsis. Herein, the authors describe mechanisms involved in the clearance of pathogen toxin from the circulation and potential interventions aimed at enhancing clearance mechanisms. The authors also describe advances in the understanding of the innate immune response as potential therapeutic targets. Finally, novel potential treatment strategies aimed at decreasing vascular leak are discussed.
Le texte complet de cet article est disponible en PDF.Keywords : Sepsis, Innate immune receptors, Pathogen, Clearance, Edema, Vascular leak
Plan
| Disclosure statement: P. Bentzer has no competing interests to declare. K.R. Walley and J.A. Russell have founded Cyon Therapeutics, which has licensed intellectual property from the University of British Columbia related to PCSK9 in sepsis. |
Vol 36 - N° 3
P. 521-530 - septembre 2015 Retour au numéro
Article précédent
- Management of Right Heart Failure in the Intensive Care Unit
- Cyrus A. Kholdani, Wassim H. Fares
- Management of Infections with Drug-Resistant Organisms in Critical Care : An Ongoing Battle
- Sergio E. Trevino, Marin H. Kollef
Bienvenue sur EM-consulte, la référence des professionnels de santé.
L’accès au texte intégral de cet article nécessite un abonnement.
Déjà abonné à cette revue ?